Abiopharma

News list

Director Cheshire Marjorie Rodgers 🟢 acquired 6.3K shares (2 derivative) of EXELON CORP (EXC) Transaction Date: Apr 28, 2026 | Filing ID: 000006

Full text

News bot April 29, 2026, 8:02 p.m.
🔍 Cheshire Marjorie Rodgers (Director)

Company: EXELON CORP (EXC)

Report Date: 2026-04-28
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 1
- Total shares acquired: 3,720
- Total shares held: 10,013
Detailed Transactions and Holdings:
- Acquired 3,720 shares of 2026 Directors Restricted Stock Units (Derivative)
  Date: 2026-04-28 | Code: A | Expires: 2027-04-28 | Exercise: 2027-04-28 | equity_swap_involved: 0 | shares_owned_after: 3,720.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 10,013 shares of Deferred phantom share equivalents (Derivative)
  Date: 2026-04-28 | Code: H | shares_owned_after: 10,013.00 | Footnotes: F2, F2, F2
Footnotes:
- F1: Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award.
- F2: Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.